PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 103 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,246,554 | -25.4% | 473,975 | +0.2% | 0.20% | -11.3% |
| Q2 2023 | $1,669,937 | +14.2% | 473,070 | 0.0% | 0.23% | +21.7% |
| Q1 2023 | $1,461,786 | -38.5% | 473,070 | -15.8% | 0.19% | -48.1% |
| Q4 2022 | $2,375,606 | +79.0% | 561,609 | +0.3% | 0.36% | +30.0% |
| Q3 2022 | $1,327,000 | -19.7% | 559,769 | -3.5% | 0.28% | -33.6% |
| Q2 2022 | $1,653,000 | -12.2% | 579,915 | -11.3% | 0.42% | -30.8% |
| Q1 2022 | $1,882,000 | -9.4% | 653,445 | -4.4% | 0.61% | -45.1% |
| Q4 2021 | $2,078,000 | – | 683,619 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |